TGF-β1 expression in EL4 lymphoma cells overexpressing growth hormone

Cellular Immunology

Volumn 240, Issue 1, 2006, Pages 22-30

  Farmer, John T ^a   Weigent, Douglas A ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Growth hormone; Lymphocytes; SMAD; TGF 1

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; GROWTH HORMONE; IODINE 125; LUCIFERASE; OLIGODEOXYNUCLEOTIDE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1; ANTIBODY; MESSENGER RNA; RADIOACTIVE IODINE; SMAD2 PROTEIN; SMAD3 PROTEIN; TGFB1 PROTEIN, MOUSE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE OVEREXPRESSION; LYMPHOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; WESTERN BLOTTING; ANIMAL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; IMMUNOLOGY; LYMPHOMA; METABOLISM; PATHOLOGY;

ANIMALS; ANTIBODIES; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; GROWTH HORMONE; IODINE RADIOISOTOPES; LYMPHOMA; MICE; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR CELLS, CULTURED;

EID: 33747869672     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2006.06.003     Document Type: Article

References (44)

1. Re R.N. The origins of intracrine hormone action. Am. J. Med. Sci. 323 (2002) 43-48
2. Re R.N. The nature of intracrine peptide hormone action. Hypertension 34 (1999) 534-538
3. Hattori N., Shimatsu A., Sugita M., Kumagai S., and Imura H. Immunoreactive growth hormone (GH) secretion by human lymphocytes: augmented release by exogenous GH. Biochem. Biophys. Res. Commun. 168 (1990) 396-401
4. Weigent D.A., Baxter J.B., and Blalock J.E. The production of growth hormone and insulin-like growth factor-I by the same subpopulation of rat mononuclear leukocytes. Brain Behav. Immun. 6 (1992) 365-376
5. Kao T.L., Supowit S.C., Thompson E.A., and Meyer III W.J. Immunoreactive growth hormone production by human lymphocyte cell lines. Cell Mol. Neurobiol. 12 (1992) 483-498
6. Varma S., Sabharwal P., Sheridan J.F., and Malarkey W.B. Growth hormone secretion by human peripheral blood mononuclear cells detected by an enzyme-linked immunoplaque assay. J. Clin. Endocrinol. Metab. 76 (1993) 49-53
7. Weigent D.A., Baxter J.B., Wear W.E., Smith L.R., Bost K.L., and Blalock J.E. Production of immunoreactive growth hormone by mononuclear leukocytes. FASEB J. 2 (1988) 2812-2818
8. Geffner M.E., Bersch N., Lippe B.M., Rosenfeld R.G., Hintz R.L., and Golde D.W. Growth hormone mediates the growth of T-lymphoblast cell lines via locally generated insulin-like growth factor-I. J. Clin. Endocrin. Metab. 71 (1990) 464-469
9. Baxter J.B., Blalock J.E., and Weigent D.A. Characterization of immunoreactive insulin-like growth factor-I from leukocytes and its regulation by growth hormone. Endocrinology 129 (1991) 1727-1734
10. Weigent D.A. Immunoregulatory properties of growth hormone and prolactin. J. Pharmacol. Therapeut. 69 (1996) 237-257
11. Arnold R.E., and Weigent D.A. The production of nitric oxide in EL4 lymphoma cells overexpressing growth hormone. J. Neuroimmunol. 134 (2003) 82-94
12. Arnold R.E., and Weigent D.A. The inhibition of superoxide production in EL4 lymphoma cells overexpressing growth hormone. Immunopharm. Immunot. 25 (2003) 159-177
13. Arnold R.E., and Weigent D.A. The inhibition of apoptosis in EL4 lymphoma cells overexpressing growth hormone. Neuroimmunomodulation 11 (2004) 149-159
14. Weigent D.A., and Arnold R.E. Expression of insulin-like growth factor-1 and insulin-like growth factor-1 receptors in EL4 lymphoma cells overexpressing growth hormone. Cell Immunol. 234 (2005) 54-66
15. J.T. Farmer, D.A. Weigent, Expression of insulin-like growth factor-2 receptors in EL4 lymphoma cells overexpressing growth hormone. Brain Behav. Immun. 2006 (in press). Pubmed 16631346.
16. Li M.O., Wan Y.Y., Sanjabi S., Robertson A.K.L., and Flavell R.A. Transforming growth factor-beta regulation of immune responses. Ann. Rev. Immunol. 24 (2006) 99-146
17. Van Obberghan-Schilling E., Kondaiah D., Ludwig R.L., Sporn M.B., and Baker C.C. Transforming growth factor beta 1 positively regulates its own expression in normal and transformed cells. J. Biol. Chem. 263 (1988) 7741-7746
18. Kitani A., Fuss I., Nakamura K., Usui T., and Strober W. Transforming growth factor (TGF)-beta1 producing regulatory T cells induce SMAD-mediated interleukin 10 secretion that facilitates coordinated immunoregulatory activity and amelioration of TGF-beta1-mediated fibrosis. J. Exp. Med. 198 (2003) 1179-1188
19. Goelik L., Constant S., and Flavell R.A. Mechanism of transformin factor beta-induced inhibition of T helper type 1 differentiation. J. Exp. Med. 195 (2002) 1499-1505
20. Lin J.T., Martin S.L., Xia L., and Gorham J.D. TGF-beta1 uses distinct mechanisms to inhibit IFN-gamma expression in CD4+ T cells at priming and at recall: differential involvement of STAT-4 and T-bet. J. Immunol. 174 (2005) 5950-5958
21. Ulloa L., Doody J., and Massague J. Inhibition of transforming growth factor beta 1 SMAD signaling by the interferon-gamma/STAT pathway. Nature 397 (1999) 710-713
22. Chen W., Frank M.E., and Jin W.W.S.M. TGF-beta released by apoptotic T cells contributes to an immunosuppressive milieu. Immunity 14 (2001) 715-725
23. Nakamura K., Kitani A., and Strober W. Cell contact dependent immunosuppression by CD4+ CD25+ regulatory T cells is mediated by cell surface bound transforming growth factor beta. J. Exp. Med. 194 (2001) 629-644
24. Lingnau K., Hoehn P., Kerdine S., Koelsch S., Neudoerfl C., Palm N., Ruede E., and Schmitt E. IL-4 in combination with TGF-beta favors an alternative pathway of Th1 development independent of IL-12. J. Immunol. 161 (1998) 4709-4918
25. Sheuach E.M. Regulatory T cells in autoimmunity. Ann. Rev. Immunol. 18 (2000) 422-449
26. Derynck R., and Zhang Y.E. Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature 425 (2003) 577-584
27. Godar S., Horejsi V., Weidle U.H., Binder B.R., Hansmann C., and Stockinger H. MGP/IGF-2 receptor complexes urokinase receptor and plasminogen for activation of transforming growth factor-beta 1. Eur. J. Immuol. 29 (1999) 1004-1013
28. Kim S.J., and Letterio J. Transforming growth factor-β signalling in normal and malignant hematopoiesis. Leukemia 17 (2003) 1731-1737
29. Liu X., Sun Y., Weinberg R.A., and Lodish H.F. Ski/Sno and TGF-beta signaling. Cytokine Growth F. R. 12 (2001) 1-8
30. Beverly S.M. Enzymatic amplification of RNA by PCR (RT-PCR). In: Ausubel F.M., Brent R., Kingston R.E., Moore D.D., Seidman J.G., Smith J.A., and Struyhl K. (Eds). Current Protocols in Molecular Biology (2001), John Wiley & Sons, New York 15.5.1-15.5.6
31. Letterio J.J., and Roberts A.B. Regulation of immune responses by TGFβ. Annu. Rev. Immunol. 16 (1998) 137-161
32. Moustakas A., Souchelnytsky S., and Heldin H.C. Smad regulation in TGF-beta signal transduction. J. Cell Sci. 114 (2001) 4359-4369
33. Dennis P.A., and Rifkin D.B. Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. Proc. Natl. Acad. Sci. USA 88 (1991) 580-584
34. Clark R. The somatogenic hormones and insulin-like growth factor-1: stimulators of lymphopoiesis and immune function. Endocr. Rev. 18 (1997) 157-179
35. Hasnain M.K., McCutcheon I.E.F.A., and Friend K.E. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr. Rev. 21 (2000) 215-240
36. Vorwek P., Wex H., Hohmann B., Mohnikek K., Schmidt V., and Mittler V. Expression of components of the IGF signaling system in childhood acute lymphoblastic leukemia. Mol. Pathol. 55 (2002) 40-45
37. Alard P., Clark S.L., and Kosiewicz M.M. Mechanisms of tolerance induced by TGF-beta treated APC: CD4 regulatory T cells prevent the induction of the immune response possibly throughout a mechanism involving TGF-beta. Eur. J. Immunol. 4 (2004) 1021-1030
38. Kim S.K., Angel P., Lafyatis R., Hattori K., and Kim K.Y. Autoinduction of TGF-beta1 is mediated by the AP-1 complex. Mol. Cell. Biol. 10 (1990) 1492-1497
39. Kao T.L., Harbour D.V., and Meyer III W.J. Immunoreactive growth hormone production by cultured lymphocytes. Ann. NY Acad. Sci. 650 (1992) 179-181
40. Groves W.E., Houts G.E., and Bayse G.S. Subcellular distribution of 125-I-labeled bovine growth hormone in rat liver and kidney. Biochim. Biphys. Acta 264 (1972) 472-480
41. McKarns S.C., Schwartz R.H., and Kaminski N.E. Smad3 is essential for TGF-β1 to suppress IL-2 production and TCR-induced proliferation, but not IL-2-induced proliferation. J. Immunol. 172 (2004) 4275-4284
42. Sebestyen A., Barna G., Nagy K., Janosi J., Kohut E., Berczi L., Mihalik R., and Kopper L. SMAD signal and TGF-beta induced apoptosis in human lymphoma cells. Cytokine 30 (2005) 228-235
43. Zhou H., Berhard E.J., Fox F.E., and Billings P.L. Induction of metalloproteinase activity in human T lymphocytes. Biochim. Biophys. Acta 2 (1993) 174-178
44. Rehfeld H.A. Mannose-6-phosphate receptors in sorting and transport of lysosomal enzymes. Biochim. Biphys. Acta 1241 (1995) 177-194